Home › Funds › DC Investments Management, LLC › MRNA
DC Investments Management, LLC position in MRNA
MODERNA INC · Health Care
DC Investments Management, LLC reported holding 68,624 shares of MRNA (MODERNA INC) in its Q2 2026 13F filing — a position valued at US$4.8M, representing 1.64% of its reported portfolio and ranking #6 among its reported holdings. DC Investments Management, LLC has disclosed MRNA holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How DC Investments Management, LLC's MRNA position evolved
DC Investments Management, LLC first disclosed a stake in MRNA in Q1 2025 at 68,624 shares (US$1.9M). The position peaked in Q2 2026 at 68,624 shares, worth US$4.8M. Across 6 filings, DC Investments Management, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 68,624 shares valued at US$4.8M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 68.62K | $1.95M | New |
| Q2 2025 | 68.62K | $1.89M | Hold |
| Q3 2025 | 68.62K | $1.77M | Hold |
| Q4 2025 | 68.62K | $2.02M | Hold |
| Q1 2026 | 68.62K | $3.49M | Hold |
| Q2 2026 | 68.62K | $4.81M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MRNA and 13F data
MRNA (MODERNA INC) is a Health Care company. 37 other funds we track also report a position in MRNA — the largest reported positions include Baillie Gifford & Co (US$1.28B), Theleme Partners LLP (US$564.3M), BANQUE PICTET & CIE SA (US$414.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MRNA
- Baillie Gifford & Co 18.21M sh · $1.28B · Q2 2026
- Theleme Partners LLP 8.06M sh · $564.27M · Q2 2026
- BANQUE PICTET & CIE SA 2.15M sh · $414.27M · Q3 2026
- Flagship Pioneering, LLC 4.63M sh · $324.39M · Q2 2026
- Douglas Lane & Associates, LLC 1.16M sh · $223.56M · Q3 2026
- Beau Ventures, LLc 1.00M sh · $192.58M · Q3 2026
- Merck & Co., Inc. 2.31M sh · $161.64M · Q2 2026
- Baron Funds 1.99M sh · $139.32M · Q2 2026
- BAMCO INC /NY/ 1.99M sh · $139.32M · Q2 2026
- IMC-Chicago, LLC 1.70M sh · $119.21M · Q2 2026
More on DC Investments Management, LLC
FAQ
How long has DC Investments Management, LLC held MRNA?
DC Investments Management, LLC has disclosed MRNA holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is DC Investments Management, LLC's current position in MRNA?
As of Q2 2026, DC Investments Management, LLC holds 68.62K shares of MRNA (MODERNA INC), valued at $4.81M, representing 1.64% of its reported portfolio and ranking #6.
Has DC Investments Management, LLC been buying or selling MRNA?
In the latest 13F filing (Q2 2026), DC Investments Management, LLC held unchanged its position in MRNA. The position peaked in Q2 2026 at 68.62K shares.
Which other funds hold MRNA?
Other major institutional holders of MRNA include Baillie Gifford & Co, Theleme Partners LLP, BANQUE PICTET & CIE SA, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.